Adriaan A. Voors

Research interests

Publications

• Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2407107

• The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

  Nature Medicine · 2022 · https://doi.org/10.1038/s41591-021-01659-1

• Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)02076-1

• Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2030183

• Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

  New England Journal of Medicine · 2020 · 10.1056/nejmoa2025797

• Angiotensin‐converting enzyme 2 ( ACE2 ), SARS‐CoV ‐2 and the pathophysiology of coronavirus disease 2019 ( COVID ‐19)

  The Journal of Pathology · 2020 · https://doi.org/10.1002/path.5471

• Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1915928

• How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

  European Heart Journal · 2019 · 10.1093/eurheartj/ehz641

• Sex differences in heart failure

  European Heart Journal · 2019 · 10.1093/eurheartj/ehz835

• Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2019 · 10.1002/ejhf.1531

• Treating Oxidative Stress in Heart Failure: Past, Present and Future

  European Journal of Heart Failure · 2018 · 10.1002/ejhf.1320

• 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

  European Journal of Heart Failure · 2016 · https://doi.org/10.1002/ejhf.592

• Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation

  Journal of the American College of Cardiology · 2016 · 10.1016/j.jacc.2016.08.048

• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  Kardiologia Polska · 2016 · 10.5603/kp.2016.0141

• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

  EP Europace · 2016 · https://doi.org/10.1093/europace/euw295

• Mitochondrial function as a therapeutic target in heart failure

  Nature Reviews Cardiology · 2016 · 10.1038/nrcardio.2016.203

• Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction

  Journal of the American College of Cardiology · 2014 · 10.1016/j.jacc.2014.08.036

• Iron deficiency in chronic heart failure: An international pooled analysis

  American Heart Journal · 2013 · 10.1016/j.ahj.2013.01.017

• EUR Observational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

  European Journal of Heart Failure · 2013 · 10.1093/eurjhf/hft050

• Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND

  European Heart Journal · 2013 · 10.1093/eurheartj/eht066

• Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction

  Journal of the American College of Cardiology · 2013 · 10.1016/j.jacc.2013.09.052

• Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis

  European Heart Journal · 2013 · 10.1093/eurheartj/eht386

• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  European Heart Journal · 2012 · https://doi.org/10.1093/eurheartj/ehs104

• The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

  The Lancet · 2012 · 10.1016/s0140-6736(12)61227-6

• Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

  The Lancet · 2012 · 10.1016/s0140-6736(12)61855-8

• ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012

  European Journal of Heart Failure · 2012 · https://doi.org/10.1093/eurjhf/hfs105

• Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

  New England Journal of Medicine · 2011 · 10.1056/nejmoa1100171

• Predictors of pregnancy complications in women with congenital heart disease

  European Heart Journal · 2010 · 10.1093/eurheartj/ehq200

• Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease

  Journal of the American College of Cardiology · 2009 · 10.1016/j.jacc.2008.08.080

Current projects

No projects listed.